1991
DOI: 10.1016/0168-8278(91)90035-a
|View full text |Cite
|
Sign up to set email alerts
|

Mutations in the S-gene affecting the immunologic determinants of the envelope protein of hepatitis B virus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

1991
1991
2006
2006

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 22 publications
0
5
0
Order By: Relevance
“…The in vivo mutation rate of hepadna virus was estimated to be lower than that of RNA viruses and higher than that of DNA viruses 28) . Presumably, such a high frequency of mutation is a result of HBV replication via reverse transcription of a RNA intermediate 29) .…”
Section: Discussionmentioning
confidence: 93%
“…The in vivo mutation rate of hepadna virus was estimated to be lower than that of RNA viruses and higher than that of DNA viruses 28) . Presumably, such a high frequency of mutation is a result of HBV replication via reverse transcription of a RNA intermediate 29) .…”
Section: Discussionmentioning
confidence: 93%
“…As such, HBsAg may be not measurable, and infection may occur even after HBV vaccination [27]. Among these mutations, the codon 145 mutation is known to be the most frequent [27,28]. The pre-S gene region of the HBV is known to serve a major role in the multiplication and etiology of the virus.…”
Section: Discussionmentioning
confidence: 99%
“…Although the subtypes are useful as epidemiological tracers of infection, they are of no pathogenetic significance. The resolution of any HBV infection culminates in production of anti-HBs, a long-lasting antibody response against the ''a'' determinant(s) of HBsAg, which confers lifelong immunity against all serotypes of HBV (5,44,45). In contrast, a failure of the immune response to the HBsAg ''a'' determinant establishes a persistent infection and leads to a spectrum of conditions with or without disease (82).…”
Section: Hepatitis Bmentioning
confidence: 99%
“…Because the overlapping S and P genes are transcribed in different open reading frames, we proposed in 1982 the concept of replication-competent HBV DNA arising from point mutations in the DNA sequence encoding the nine amino acid residues 139 to 147, which determine the immunoreactivity of the ''a'' determinant of HBsAg (5,82,84). Such genetic variants with amino acid substitutions in these nine residues of HBsAg could bestow a conformational change adequate to allow escape from the otherwise neutralizing anti-HBs (44). Although recombinant HBsAg used in a monoclonal vaccine against HBV induces a potent anti-HBs response and provides protection against infection with HBV of all sero-types, Carman et al (14) have reported a vaccine-induced escape mutant of HBV in successfully vaccinated children who had simultaneously circulating HBsAg and anti-HBs.…”
Section: Hepatitis Bmentioning
confidence: 99%
See 1 more Smart Citation